Document is current
Any future updates will be listed below
-
Authors
Güzel, Nergis https://orcid.org/0009-0002-1030-2179
Schumacher, Yannic
Kricheldorf, Kim
Vieri, Margherita
Kirschner, Martin
Gerhard-le Gars, Anne-Claire
Panse, Jens https://orcid.org/0000-0001-6316-3112
Tometten, Mareike
Walter, Jeanette
Gehrig, Andrea
Kunstmann, Erdmute
Holthöfer, Laura
Schweiger, Susann
Wolff, Daniel
Kraft, Florian https://orcid.org/0000-0002-5324-9155
Elbracht, Miriam https://orcid.org/0000-0001-5088-1369
Kurth, Ingo
Brümmendorf, Tim H.
Meyer, Robert https://orcid.org/0000-0002-5693-2216
Beier, Fabian
-
Funding
Funding for this research was provided by:
DFG grant
Lichterzellen-Stiftung
- License Information
-
More Information
Article History
Received: 16 May 2025
Revised: 13 July 2025
Accepted: 5 August 2025
First Online: 25 August 2025
Competing interests
: This work was supported by a grant from Lichterzellen-Stiftung to THB and DFG grant (DFG BE 7836-3/1) to FB. THB and FB have a long-ranging scientific collaboration with Repeat Dx., Vancouver, Canada. DW received honoraria from Novartis, Incyte, Sanofi and Neovii.
: All methods were performed in accordance with the relevant guidelines and regulations. The study protocol was approved by the Ethics Committee at the Medical Faculty of RWTH Achen University, under reference number EK332/20 and EK225/14. Informed consent was obtained from all participants prior to their inclusion in the study.
